Topcon Healthcare and deepeye Medical Partner to Bring AI-Guided Retinal Therapy Planning Across Europe
Capelle aan den IJssel, The Netherlands / Munich, Germany — October 21, 2025 — Topcon Healthcare, Inc., a global leader in digital health and ocular data solutions, and deepeye Medical GmbH, a leading AI health-tech innovator, today announced a strategic partnership to integrate and distribute deepeye® TPS (Therapy Planning Support) within Harmony™, Topcon Healthcare’s connected-care platform. The collaboration delivers in-workflow, AI-guided retinal therapy insights directly from ocular imaging to clinics across Europe, within a vendor-inclusive, cloud-ready environment.
Aligned with Topcon’s Healthcare from the Eye™ vision, the integration combines CE-marked AI decision support with unified data management to help clinicians personalize treatment and improve efficiency. From image acquisition to AI-supported therapy planning, providers can work inside their existing imaging workflows without switching systems or compromising data integrity.
“By bringing deepeye® TPS into our connected-care platform, we’re delivering actionable, AI-driven insights within clinicians’ imaging workflows,” said Krysten Williams, Head of Digital Health Solutions & Clinical Development, EMEA, Topcon Healthcare. “It’s another step toward scalable, connected eye care across Europe.”
deepeye® TPS: CE-Marked, Vendor-Inclusive, Built for Daily Practice
deepeye® TPS supports therapy planning such as anti-VEGF treatment for nAMD by analyzing OCT images and providing structured, second-opinion guidance based on large, real-world datasets validated in clinical settings. The software is vendor-inclusive and works with most OCT devices, helping practices streamline intravitreal injection workflows, support patient education, and improve consistency of care.
Used in specialized ophthalmology clinics, the combination of deepeye® TPS and Harmony™ helps close the retina-expert gap by making expert-level decision support available anytime and anywhere across the care team.
Clinician Perspective
Dr. Fabian Vivell: “Since the integration, my workflow has noticeably accelerated. The automatic analysis of OCT images provides structured, immediately usable results, reducing time to decision and giving me more time with patients. Subtle changes are easier to detect, and earlier activity signals help me adjust therapy in time.”
Availability
Topcon Healthcare will begin the rollout of deepeye® TPS in Germany, with additional European markets to follow. For more information, please contact your local Topcon representative.
About deepeye Medical GmbH
deepeye Medical is a German healthtech company dedicated to preventing avoidable blindness caused be retinal diseases. Through the use of AI-powered predictaive analysis, deepeye assists in therapeutic decision-making for ophthalmologists, similar to double reading by two doctors, which studies have shown can optimize patient outcomes and increase treatment adherence. The solution, deepeye® TPS (Therapy Planning Support), provides precise treatment recommendations based on real-world clinical data. The company partners with all leading pharma companies, European and US research institutions, and medical device manufacturers like Topcon to drive innovation on retinal care.
deepeye® TPS is a CE-marked medical device. In addition, it fulfills the requirements of the EU AI Act, e.g. in terms of transparency, human oversight, and traceability. Important information about the scope of application and the limitations of the algorithm can be found in the electronic instructions for use.
For more information, please visit www.deepeye-medical.com
About Topcon Healthcare Inc.
Topcon Healthcare, Inc. is part of Topcon Corporation, a leading provider of digital healthcare solutions. Our vision is to improve access and quality of healthcare while decreasing the cost of care. To achieve this vision, we created Healthcare from the Eye™, a connected care ecosystem using AI-powered disease detection and management applied to noninvasive retinal imaging.
For more information, please visit topconhealthcare.com
Media Contacts:
deepeye Medical GmbH
[email protected]
Topcon Healthcare Inc.
Mely Medel
Head of Marketing EMEA
[email protected]